Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1995-07-11
1999-02-09
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
058695362
ABSTRACT:
A pharmaceutical composition for treating hyperkinetic disorders, which contains as an active ingredient an effective amount of 2-(4-methylamino butoxy)diphenylmethane, is provided. A method of treating hyperkinetic disorders with said pharmaceutical composition and use of said diphenylmethane for preparing said composition are also provided.
REFERENCES:
patent: 4024282 (1977-05-01), Kikumoto et al.
patent: 4060641 (1977-11-01), Kikumoto et al.
patent: 4071559 (1978-01-01), Kikumoto et al.
patent: 4507322 (1985-03-01), Kuriyama et al.
Nomura, Pharmacology Biochemistry and Behaviour, vol. 42, Nov. 4, 1992 pp. 721-731.
Fox et al, Drug Safety, vol. 9, Nov. 1, 1993, pp. 38-50.
Meller et al., Primary Care, vol. 14, Nov. 4, 1987, pp. 745-758.
Medline Abstract #92383279, Nomura, "Effects of bifemline on discrimination learning of serotmergy-dysfunction rats", pharmacol. Biochm. Behav; 42(4) pp. 721-731 Aug. 1992.
Medline Abstract 88203861, Gold et al, "Methyseigid Penetrates the hyproactivity produced by MDMA in rats", Pharmacol Biochem. Behav (Mar. 1988), 29(3), 645-648.
Tamura Tomoko
Tanaka Tadashi
Tobe Akihiro
MacMillan Keith D.
Mitsubishi Chemical Corporation
LandOfFree
Treatment of hyperkinetic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of hyperkinetic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hyperkinetic disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1948809